Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) Sees Large Decrease in Short Interest

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) was the recipient of a significant decline in short interest in the month of June. As of June 30th, there was short interest totaling 65,513 shares, a decline of 54.0% from the June 15th total of 142,536 shares. Based on an average daily volume of 1,245,678 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the company’s shares are sold short.

Analyst Upgrades and Downgrades

CLPBY has been the topic of a number of recent analyst reports. Kepler Capital Markets raised shares of Coloplast A/S to a “strong-buy” rating in a research note on Wednesday, May 20th. The Goldman Sachs Group cut shares of Coloplast A/S from a “hold” rating to a “strong sell” rating in a research note on Tuesday, April 7th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Coloplast A/S presently has a consensus rating of “Hold”.

Coloplast A/S Stock Performance

Coloplast A/S stock opened at $6.28 on Thursday. The company has a market cap of $14.15 billion, a price-to-earnings ratio of 44.86, a price-to-earnings-growth ratio of 1.93 and a beta of 0.22. Coloplast A/S has a 12 month low of $5.64 and a 12 month high of $10.03. The company has a debt-to-equity ratio of 1.66, a current ratio of 1.75 and a quick ratio of 1.09. The stock’s 50-day moving average is $6.08 and its 200-day moving average is $7.02.

Coloplast A/S (OTCMKTS:CLPBY) last issued its earnings results on Tuesday, May 12th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.01. Coloplast A/S had a return on equity of 33.15% and a net margin of 7.46%.The business had revenue of $1.11 billion during the quarter, compared to analysts’ expectations of $1.11 billion. Equities analysts anticipate that Coloplast A/S will post 0.38 earnings per share for the current year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.